Can Biopsy Find Silent Endometritis Before FET?

Table of Contents

Can an endometrial biopsy detect silent chronic endometritis before FET?

For many women preparing for a frozen embryo transfer, the biggest worry is not only embryo quality. It is also the question: “Is my uterus truly ready?” When scans look normal, periods are regular, and there is no pain or discharge, it can feel confusing when a doctor suggests checking for silent chronic endometritis before FET.

Yes, an endometrial biopsy can help detect silent chronic endometritis before FET, especially when the tissue is examined carefully with appropriate pathology methods such as CD138 immunostaining. But it is not a routine test for every IVF patient. It is usually considered when there is a clinical reason, such as repeated implantation failure, recurrent pregnancy loss, previous uterine infection, unexplained thin or irregular lining, or repeated transfer cancellations.

At ARC Fertility Hospitals, evaluation before embryo transfer is approached with one central idea: the embryo and the endometrium both matter. A good embryo still needs a receptive, healthy uterine environment. That is why some women may be advised to investigate hidden inflammation before proceeding with FET.

What is silent chronic endometritis?

Chronic endometritis is a persistent, low-grade inflammation of the endometrium, the inner lining of the uterus. It is different from acute pelvic infection, which often causes fever, severe pain, or foul-smelling discharge. Chronic endometritis can be quiet. Many women have no obvious symptoms at all.

This is why it is called “silent” in fertility discussions. A woman may have normal cycles, a normal ultrasound, and no pelvic discomfort, yet microscopic inflammation may still be present in the lining. In some cases, doctors consider it when implantation has repeatedly failed despite apparently good embryos and well-planned transfer cycles.

The concern is not that chronic endometritis makes pregnancy impossible. Rather, untreated inflammation may interfere with the delicate communication between the embryo and the uterine lining. Implantation depends on immune balance, blood flow, hormone response, and endometrial receptivity. If inflammation is present, the lining may not respond as predictably as expected.

How does an endometrial biopsy help?

An endometrial biopsy is a procedure where a small sample of uterine lining tissue is collected, usually through the cervix using a thin instrument. The sample is then examined under a microscope by a pathologist. In suspected chronic endometritis, the important finding is the presence of plasma cells within the endometrial tissue.

Because plasma cells can be difficult to identify on routine microscopy alone, many fertility specialists prefer CD138 immunostaining. CD138 is a marker that helps highlight plasma cells more clearly. This can improve diagnostic confidence, especially in cases where inflammation is subtle.

The value of biopsy is that it looks directly at the lining, rather than assuming the lining is healthy based only on thickness. Ultrasound can tell us about endometrial thickness and pattern, but it cannot reliably detect microscopic inflammation. That is where tissue testing can provide additional information.

When is biopsy usually considered before FET?

Not every woman needs an endometrial biopsy before frozen embryo transfer. If this is a first FET, the uterus looks normal, there is no history suggesting infection or miscarriage, and the treatment plan is straightforward, many doctors may proceed without biopsy.

Biopsy becomes more relevant when there is a pattern that needs explanation. For example, if a woman has had more than one unsuccessful embryo transfer using good-quality embryos, the care team may look beyond embryo grading and review the uterine environment. Similarly, if there have been recurrent early losses or a history of intrauterine procedures, pelvic infection, or abnormal bleeding, a closer endometrial evaluation may be reasonable.

Patients often ask whether this test should be done “just to be safe.” The answer depends on the full fertility history. Good fertility care is not about doing every available test. It is about choosing tests that are likely to change management. A biopsy is more useful when the result may guide treatment, timing, or whether to postpone transfer until the lining is optimised.

What happens if chronic endometritis is found?

If biopsy suggests chronic endometritis, the next step is usually treatment before embryo transfer. Doctors may prescribe antibiotics based on clinical judgement, test findings, and the patient’s history. In some situations, additional evaluation may be recommended to look for uterine factors such as polyps, adhesions, or retained tissue, because these can sometimes coexist with inflammation.

After treatment, some clinicians may repeat the biopsy to confirm resolution, especially in recurrent implantation failure or recurrent pregnancy loss. Others may proceed to FET if symptoms, history, and treatment response are reassuring. The decision is individual.

It is important to understand that treating chronic endometritis does not guarantee implantation or pregnancy. IVF outcomes depend on embryo genetics, egg and sperm factors, age, uterine receptivity, hormonal preparation, and overall medical context. But when silent inflammation is present, identifying and treating it may remove one possible obstacle before FET.

Does biopsy affect the FET timeline?

A biopsy can add time to the preparation cycle. It is often performed in a specific phase of the cycle, depending on the reason for testing and the clinic protocol. If chronic endometritis is detected, treatment may delay embryo transfer by a few weeks or until the doctor feels the lining is ready.

This delay can feel emotionally difficult. Many women reach FET after months or years of waiting, and any postponement feels like another barrier. But from a treatment-planning perspective, delaying transfer to correct a potentially treatable uterine issue may be more sensible than proceeding into uncertainty.

Some patients also ask whether medications used around embryo transfer, such as blood thinners or anti-inflammatory strategies, can replace biopsy. These are different decisions. If your doctor is discussing uterine inflammation, implantation history, or clotting-related concerns, it may help to understand how supportive medications are considered around transfer. You can read more about low-dose aspirin and Lovenox before embryo transfer as part of that wider conversation.

Is the biopsy painful or risky?

Most women describe endometrial biopsy as brief cramping, similar to strong period pain, lasting a short time. Some spotting can occur afterwards. Doctors usually explain whether pain relief is needed before the procedure and what symptoms should be reported later.

Serious complications are uncommon, but no procedure is completely risk-free. Infection, heavier bleeding, or significant pain should be reported promptly. If you are anxious about the procedure, tell your fertility team. A good clinic will explain the steps, timing, discomfort level, and aftercare clearly rather than expecting you to tolerate uncertainty silently.

Biopsy, hysteroscopy, and other tests: how do they differ?

One reason patients feel confused is that several uterine tests may be discussed before FET. They do not all answer the same question. A scan checks structure and lining thickness. Hysteroscopy allows the doctor to look inside the uterine cavity. Biopsy examines tissue at the microscopic level. Sometimes these tests complement each other.

If you are choosing care and want a team that explains not just what test is being done but why it matters, ARC Fertility Hospitals offers patient-centred fertility evaluation. Many women searching for a Fertiliy hospital in Chennai are not simply looking for IVF treatment; they are looking for clarity before making emotionally heavy decisions. ARC’s approach focuses on evidence-based assessment, realistic counselling, and individualised treatment planning.

Summary: common tests before FET and what they show

Test or Evaluation What it can show What it may not show clearly When doctors may consider it
Transvaginal ultrasound Endometrial thickness, pattern, fibroids, ovarian response, visible fluid Microscopic inflammation such as silent chronic endometritis Routine FET monitoring and baseline uterine assessment
Endometrial biopsy Tissue-level findings, including plasma cells suggestive of chronic endometritis when properly stained Full uterine cavity shape or small structural lesions unless combined with other tests Repeated implantation failure, recurrent loss, unexplained lining concerns, or infection history
Hysteroscopy Polyps, adhesions, septum, cavity abnormalities, suspicious areas inside the uterus Subtle cellular inflammation unless tissue is sampled Abnormal scan findings, recurrent failed transfers, abnormal bleeding, suspected cavity issues
Hormonal review Whether estrogen and progesterone preparation is appropriate for FET Hidden infection or tissue inflammation Before medicated FET cycles or when lining response is inconsistent

What should you ask your doctor before agreeing to biopsy?

Before the test, ask why it is being recommended in your specific case. Is it because of failed implantation, miscarriage history, lining irregularity, previous infection, or a planned protocol change? Also ask how the sample will be analysed, whether CD138 staining will be used, what a positive result means, and whether treatment will delay FET.

Cost is another practical concern. Biopsy cost can vary depending on clinic protocol, pathology method, whether hysteroscopy is also done, and whether repeat testing is needed. Instead of looking at the test in isolation, ask whether the result is likely to change your next step. That is often the best way to decide whether the cost and delay are justified.

For women preparing for FET, the goal is not to search endlessly for problems. It is to identify meaningful, treatable factors before transfer. If chronic endometritis is suspected, biopsy can be a useful tool because it answers a question that scans often cannot.

Final thoughts

So, can an endometrial biopsy detect silent chronic endometritis before FET? Yes, it can help detect it, particularly when the tissue is examined with the right pathology techniques. But it should be used thoughtfully, not automatically. The best decision depends on your IVF history, embryo factors, previous outcomes, uterine findings, and emotional readiness for any delay.

If you are unsure whether biopsy is right before your next FET, speak with a fertility specialist who can review your full history rather than giving a one-size-fits-all answer. Patients looking for the Best Fertiliy hospital in Chennai often need exactly that: careful explanation, honest expectations, and a treatment plan that respects both medical evidence and emotional reality.

Frequently Asked Questions

Get answers to common questions about IVF treatment at ARC Fertility

Can chronic endometritis be present without any symptoms?
+

Yes. Chronic endometritis can be silent, meaning there may be no pain, fever, discharge, or obvious menstrual change. This is why it may only be suspected after repeated implantation failure, recurrent pregnancy loss, abnormal lining response, or certain uterine history.

Is an endometrial biopsy required before every FET?
+

No. An endometrial biopsy is not routinely needed for every frozen embryo transfer. It is usually considered when the doctor has a reason to investigate the uterine lining more deeply, such as previous failed transfers, recurrent losses, suspected inflammation, or unexplained lining concerns.

What does the biopsy look for in chronic endometritis?
+

The biopsy sample is examined for signs of inflammation, especially plasma cells in the endometrial tissue. Many fertility specialists prefer CD138 immunostaining because it can help identify plasma cells more clearly than routine microscopy alone.

If chronic endometritis is treated, will FET definitely work?
+

No treatment can guarantee implantation or pregnancy. Treating chronic endometritis may remove a possible uterine factor, but FET success also depends on embryo genetics, age, hormone preparation, sperm and egg factors, and overall reproductive health.

Will an endometrial biopsy delay my embryo transfer?
+

It may. The biopsy needs to be scheduled at an appropriate time, and if chronic endometritis is found, your doctor may recommend treatment before proceeding. This can delay transfer by a few weeks, but the aim is to improve uterine readiness before placing the embryo.

Is endometrial biopsy the same as hysteroscopy?
+

No. Hysteroscopy allows the doctor to look inside the uterine cavity and identify structural issues such as polyps or adhesions. Endometrial biopsy examines a tissue sample under the microscope. In some cases, both may be used because they answer different questions.

What should I ask my fertility doctor before having the biopsy?
+

Ask why the biopsy is recommended for your case, whether CD138 staining will be used, how results will change the FET plan, whether treatment is needed if the result is positive, and whether repeat testing may be advised before transfer.

Contents

Get FREE Fertility tests worth Rs.4500.

Book your test

India

WAIT BEFORE YOU LEAVE...

Claim FREE Fertility Tests Worth ₹4,500.

Start your journey with expert care today at zero cost.

Book Your Free Slot

Submit the details below, and our team will contact you within 24 hours to confirm your booking.

India

Planning Your Fertility Journey?

Get fertility tests worth ₹ 4,500 at no cost, including

Book Your Free Slot

Submit the details and our team will contact you to confirm your booking.

India